Hostname: page-component-89b8bd64d-dvtzq Total loading time: 0 Render date: 2026-05-06T18:05:23.178Z Has data issue: false hasContentIssue false

Montmorillonite as an Anti-Tuberculosis Rifampicin Drug Carrier: DFT and Experimental Study

Published online by Cambridge University Press:  01 January 2024

Eva Scholtzová*
Affiliation:
Institute of Inorganic Chemistry, Slovak Academy of Sciences, Dúbravská cesta 9, 84536 Bratislava, Slovakia
Luboš Jankovič
Affiliation:
Institute of Inorganic Chemistry, Slovak Academy of Sciences, Dúbravská cesta 9, 84536 Bratislava, Slovakia
Daniel Tunega
Affiliation:
Institute for Soil Research, Department of Forest and Soil Sciences, University of Natural Resources and Life Sciences Vienna, Peter-Jordan-Strasse 82, 1190 Vienna, Austria
Rights & Permissions [Opens in a new window]

Abstract

A hybrid of montmorillonite (Mnt) and rifampicin (RIF) was synthesized and the structure and stability of the drug carrier system clarified. Density functional theory calculations involving dispersion corrections (DFT-D3) were performed to characterize interactions acting in the interlayer space of montmorillonite intercalated with rifampicin. The structure and stability of the RIF-Mnt intercalated complex were determined. Calculations revealed the deformation of the molecular structure of rifampicin after intercalation into the Mnt interlayer space due to the clay environment. The ansa chain of RIF was bent in the interlayer space compared with the structure of the RIF molecule in the monocrystal. RIF was keyed into the Mnt surface by means of numerous hydrogen bonds of weak to moderate strength. The calculated vibrational spectrum from ab initio molecular dynamics (AIMD) was in good agreement with the FTIR measured spectra and helped to analyze the overlapped vibrational bands. Based on analysis of structural stability, theoretical calculations revealed that Mnt is a suitable drug carrier for delayed release of the RIF drug. Batch adsorption experiments showed the large adsorption capacity of montmorillonite for RIF.

Information

Type
Original Paper
Creative Commons
Creative Common License - CCCreative Common License - BY
This is an Open Access article, distributed under the terms of the Creative Commons Attribution license (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted re-use, distribution, and reproduction in any medium,provided the original work is properly cited.
Copyright
Copyright © 2023 The Authors.
Figure 0

Fig. 1 The structure of RIF. Its heterocyclic structure containing a naphthoquinone core is spanned by an aliphatic ansa chain (upper part of the RIF structure); the red arrow highlights the protonated site (N50)

Figure 1

Fig. 2 Proposed model of the RIF-Mnt structure; the red arrow highlights the protonated site (N50)

Figure 2

Fig. 3 Comparison of the RIF structure in the molecular crystal (black) with the optimized RIF structure in the interlayer space of montmorillonite (orange); the red arrow highlights the protonated site (N50)

Figure 3

Fig. 4 Network of hydrogen bonds in the RIF-Mnt structure. Intra hydrogen bonds: ORIF–H···ORIF (lime), N–H···N (light blue), C–H···N (olive) and C–H···ORIF (orange); Ow–H···Ow (magenta), and inter hydrogen bonds Ow–H···Ob (blue), ORIF–H···Ob (cyan), C–H···Ob (black), N–H···Ob (petrol) and Ow–H···ORIF (mint). The red arrow highlights the protonated site (N50)

Figure 4

Table 1 The D–H···A hydrogen bond lengths (min, median, max) [Å] present in the RIF-Mnt structure (RIF – rifampicin, w – water, b – basal, D – donor, A – acceptor)

Figure 5

Fig. 5 Calculated (red) and experimental (black) FTIR spectra of the RIF-Mnt structure and FTIR spectrum of the RIF molecular crystal (blue)

Figure 6

Fig. 6 Adsorption isotherm data of rifampicin on Na-montmorillonite and their fit to: (a) Langmuir (cads = Γmax.KL. cis/(1 + K KL.cis)) and (b) Freundlich (cads = KF. cisα) isotherm models. cads is the adsorbed concentration; cis is initial concentration of solutions; KL and KF are adsorption constants; Γmax is the maximal saturation of RIF; and α is the exponent